A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer

Stopped This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.

Conditions

• Advanced Lung Carcinoma

Interventions

• DRUG: TQB3616 capsules
• DRUG: Anlotinib Hydrochloride capsules
• DRUG: Irinotecan Hydrochloride for Injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.